According to our findings, the MAFLD group had higher levels of TG, LDL, ALT, AST, and cholesterol than the control group, a significant association between abnormal lipid profile and fatty liver as cholesterol, TG, LDL, and HDL was established by Tayyem et al. [17], the same result was shown by Sathiaraj et al., who concluded that total cholesterol, TG, and low HDL were statistically significant high in patients with NAFLD [18]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.